Product Details

Atorvastatin + Ezetimibe for Tablets BP is manufactured to strict BP-standard specifications for use in the management of high cholesterol. It is prescribed for patients requiring dual-mechanism lipid-lowering therapy.

The tablets combine:

• Atorvastatin Calcium (equivalent to Atorvastatin) — an HMG-CoA reductase inhibitor (statin) that reduces cholesterol synthesis in the liver, lowering LDL cholesterol levels
• Ezetimibe — a cholesterol absorption inhibitor that blocks intestinal absorption of dietary and biliary cholesterol, further reducing LDL cholesterol levels

Atorvastatin + Ezetimibe for Tablets BP is indicated in the management of primary hypercholesterolemia and mixed dyslipidemia, particularly where statin therapy alone provides insufficient control. As a result, it is commonly prescribed in cardiology and general medicine settings for long-term cardiovascular risk reduction.

Key Features:

• Manufactured to BP-standard compliance for consistent quality
• Dual-mechanism formulation supports enhanced LDL cholesterol reduction
• Film-coated tablets ensure stability and ease of swallowing
• Accurate, consistent potency supports reliable daily dosing
• Suitable for long-term outpatient cardiovascular risk management
• Suitable for hospital pharmacies, clinics, and retail pharmacy supply